ENACT group visit for Primary Care

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Primary Care+1 MoreENACT group visit - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether a group visit intervention can help patients better align their medical care with their values. Patients will meet in groups of 8-10, facilitated by a geriatrician and social worker, for two 2-hour sessions, one month apart.

Eligible Conditions
  • Primary Care
  • Advance Care Planning

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 6 Months

6 Months
Percent of Retention
6 months
Number of Participants with New Advanced Care Planning (ACP) documentation in their electronic health record at 6 Months
Baseline, 6 months
Composite of advanced care planning documentation
Measure of decision self-efficacy
Measure of readiness for ACP
Patient Reported Outcome Measurement Information System Global Health Scores
Telephone Montreal Cognitive Assessment (T-MoCA) scores
The Quality of Communication (QOC)
Month 3
Percent of Recruitment (Reach)

Trial Safety

Safety Progress

1 of 3

Trial Design

4 Treatment Groups

Participants: Mailed Resources
1 of 4
Clinic Stakeholders
1 of 4
Caregivers
1 of 4
Participants: ENACT Group Visit
1 of 4

Active Control

Experimental Treatment

600 Total Participants · 4 Treatment Groups

Primary Treatment: ENACT group visit · No Placebo Group · N/A

Participants: ENACT Group Visit
Behavioral
Experimental Group · 1 Intervention: ENACT group visit · Intervention Types: Behavioral
Participants: Mailed Resources
Behavioral
ActiveComparator Group · 1 Intervention: Mailed Resources · Intervention Types: Behavioral
Clinic StakeholdersNoIntervention Group · 1 Intervention: Clinic Stakeholders · Intervention Types:
CaregiversNoIntervention Group · 1 Intervention: Caregivers · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ENACT group visit
2017
N/A
~110

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,594 Previous Clinical Trials
1,926,796 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,414 Previous Clinical Trials
3,483,622 Total Patients Enrolled
Hillary Lum, MD, PhDPrincipal InvestigatorUniversity of Colorado, Denver
1 Previous Clinical Trials
110 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been to a clinic in the past year.
You are willing to receive care in English or Spanish.